|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Sector | Acquiring Party | Transferring Party |
|---|---|---|
| Biopharmaceuticals | Adams Respiratory Therapeutics, Inc. | Cornerstone BioPharma, Inc. |
| Cornerstone will transfer the Humibid product line to Adams, and in return Adams will transfer their AlleRx line to Cornerstone. This Deal will add more... | ||
| Biopharmaceuticals | Aeterna Zentaris Inc. (AEZS) | Artium Biotechnologies Inc. |
| Increases Aeterna’s presence in the North American market for active ingredients and specialty chemicals. Deal value about $23.8 more... | ||
| Biopharmaceuticals | Antisoma Plc. | Aptamera Inc. |
| Expands Antisoma’s cancer drug portfolio. Deal value about $22 more... | ||
| Biopharmaceuticals | Bain Capital Partners,DLJ Merchant Banking, J.P. Morgan Partners and Thomas H. Lee Partners | Warner Chilcott |
| Provides Warner Chilcott with significant funding to grow in woman’s healthcare and dermatology markets. Deal value about $3.1 more... | ||
| Biopharmaceuticals | Bayer AG (BAYG:DE) | GlaxoSmithKline PLC |
| Bayer acquired the sole marketing rights outside the United States of Levitra, a drug used for erectile dysfunction. Deal value about $260 more... | ||
| Biopharmaceuticals | Biacore International AB (SSE:BCOR) | FLEXChip Systems |
| FLEXChip strengthens Biacore's global position in the field of protein interaction analysis. Deal value about $4 more... | ||
| Biopharmaceuticals | C.B. Fleet Company, Inc. | CCS |
| CCS expands CCS' presence in Nordic region, as well as broadens its product more... | ||
| Biopharmaceuticals | Epimmune Inc. | IDM S.A. (Immuno-Design Molecules) |
| The newly formed company will focus on the development of seven product candidates in clinical development for cancer and infectious diseases. The more... | ||
| Biopharmaceuticals | Genetronics Biomedical Corp. (GEB) | Inovio AS. |
| Adds to Genetronics’ DNA therapies. Deal value about $13 more... | ||
| Biopharmaceuticals | Genzyme Corporation (GENZ) | Verigan AG (Germany) |
| Advances Genzymes global orthopedic franchise, with a strong presence in Europe and Australia. Deal value about $10 million with $40 million more... | ||
| Biopharmaceuticals | Invitrogen Corporation, (Nasdaq: IVGN) | Zymed Laboratories Inc. |
| Zymed complements Invitrogen's technology adding more than 2,000 antibodies and related products. Deal value about $ 60 more... | ||
| Biopharmaceuticals | Johnson & Johnson (JNJ) | TransForm Pharmaceuticals, Inc. |
| TransForm will be added to J&J’s line of pharmaceutical research and development. Deal value about $230 more... | ||
| Biopharmaceuticals | LAM Pharmaceutical, Corp. | New World Kellerton |
| LAM obtains new drugs and a GMP Chinese plant. Deal value about $14 million (mostly in LAM more... | ||
| Biopharmaceuticals | Manhattan Pharmaceuticals, Inc. (OTCBB:MHTT) | Tarpan Therapeutics, Inc. |
| Gives Manhattan rights to three key therapeutic more... | ||
| Biopharmaceuticals | MorphoSys AG (Frankfurt Stock Exchange MOR) | Biogenesis Ltd. (U.K.) and Biogenesis Inc. (U.S.) |
| Establishes MorphoSys as one of the top five European suppliers of antibodies, as well as providing it access to new antibody more... | ||
| Biopharmaceuticals | Novartis AG (NVS) | Eon Labs, Inc. (Nasdaq:ELAB) |
| Both deals significantly fortify Novartis as the leading generic drug maker in the world. The Eon deal is valued at over $8.0 billion and the Hexal more... | ||
| Biopharmaceuticals | Pfizer Inc. (PFE) | Idun Pharmaceuticals Inc. |
| Augment's Pfizer's R&D. Pfizer can advance Idun's caspases-oriented pipeline through development and commercialization, providing a more... | ||
| Biopharmaceuticals | PPD, Inc. (PPI) | SurroMed, Inc. |
| Adds biomarker discovery and patient sample analysis more... | ||
| Biopharmaceuticals | Protein DesignLabs Inc. | ESP Pharma, Inc. |
| ESP will add commercialization products and more pharmaceuticals to Protein Design Labs portfolio. Deal value about $500 more... | ||
| Biopharmaceuticals | Schering-Plough Corporation, (SGP) | NeoGenesis Pharmaceuticals, Inc. |
| Strengthens Schering’s capabilities in innovative drug more... | ||
| Biopharmaceuticals | Sigma-Aldrich Corporation (SIAL) | JRH Biosciences, Inc. |
| Strengthens Sigma-Aldrich‘s ability to supply its customers with cell culture products. Deal value about $370 million, JRH’s sales are $150 more... | ||
| Biopharmaceuticals | SurModics, Inc. (SRDX) | InnoRx, Inc. |
| Extends SurMeodics reach into ophthalmology segments. Deal value about $10 more... | ||
| Biopharmaceuticals | Takeda Pharmaceutical Company Ltd | Syrrx Inc |
| Syrrx’s technologies and R&D pipeline omplement s Takeda’s established research more... | ||
| Biopharmaceuticals | Tanox, Inc. (TNOX) | Sunol Tissue factor antagonist program, a division of Sonol Molecular Corporation |
| Tanox obtains Sunol’s tissue-factor antagonist cH36- an anti factor monoclonal antibody in development for lung injury, and acute respiratory more... | ||
| Biopharmaceuticals | Warburg Pincus | West Pharmaceuticals Services, Inc. (WST) |
| West will now have the funding to expand its drug delivery platform. Deal value about $7 million, plus $9 million in contingent payments and a $40 more... | ||
| Data Management/ Healthcare IT | Affiliated Computer Services, Inc. (NYSE:ACS) | Superior Consultant Holdings Corporation (NASDAQ:SUPC) |
| A complementary acquisition which is expected to bolster Affiliated’s existing health care IT services group. Deal value -- $106m, on Superior more... | ||
| Data Management/ Healthcare IT | Cerner Corporation (CERN) | VitalWorks Inc. (Nasdaq:VWKS) |
| VitalWorks divests its medical division to Cerner. Deal, valued at about $100 million, expands Cerner’s existing products and services focused more... | ||
| Data Management/ Healthcare IT | Dendrite International Inc. (DRTE) | BuzzeoPDMA, Inc. |
| The combination of the two companies makes for a more complete sample and compliance management more... | ||
| Data Management/ Healthcare IT | HealthStream | Data Management & Research Inc. |
| HealthStream intends to market DMR’s services to providers to help with recruiting and retention of staff. Deal value about $10.6 million. more... | ||
| Data Management/ Healthcare IT | Infotrieve, Inc. | GenSys Software, Inc. |
| GenSys/ELN will be the platform for Infotrieve’s life science electronic more... | ||
| Data Management/ Healthcare IT | McKesson Corporation | Intelliclaim Incorporated |
| Reinforces McKesson’s position as the leading supplier of claims auditing products and services for more... | ||
| Data Management/ Healthcare IT | Tripos, Inc. (Nasdaq:TRPS) | Optive Research, Inc. |
| Expands Tripos’s offerings enabling its customers to accelerate commercialization of drugs and chemical compounds Deal value about $8 more... | ||
| Data Management/ Healthcare IT | Varian Medical Systems, Inc., (NYSE:VAR) | Sigma Micro Informatique Conseil |
| Enables Varian to provide information management technology to Europe. Deal value about $13 million, revenues under $7 more... | ||
| Diagnostics | Agilent Technology Inc. (A) | Computational Biology Corp. |
| Agilent attains access to important intellectual property that will enable the company to provide microarray solutions for disease research, drug more... | ||
| Diagnostics | Gen-Probe (GPRO) | Corixa (CRXA) |
| Gen-Probe licenses from Corixa rights to develop molecular diagnostic tests for potential markers of Genitourinary and other cancers. This agreement more... | ||
| Diagnostics | Inverness Medical Innovations, Inc. (AMEX: IMA) | Binax, Inc. |
| Expands Inverness’s proprietary technology base into respiratory and other infectous disease diagnostics. Deal value - $33m in Inverness stock more... | ||
| Diagnostics | Inverness Medical Innovations, Inc. (AMEX: IMA) | Ischemia Technologies, Inc. |
| Ischemia helps Inverness expand in the cardio market; Inverness can help to commercialize the Ischmia products. Ischemia had only $1million in more... | ||
| Diagnostics | Laboratory Corporation of America Holdings (NYSE:LH) | Esoterix, Inc. |
| Esoterix is being sold Behrman Capital, a private equity firm for $150 million cash. Esoterix was a "roll-up" of fragmented lab service more... | ||
| Distribution | Henry Schein, Inc. (HSIC) | Ash Temple Ltd |
| A synergistic acquisition that doubles Schein's 100-person sales force in Canada. Terms were not disclosed, but Ash Temple generates revenues more... | ||
| Distribution | Medco Health Solutions, Inc. | Accredo Health, Inc. |
| Adds specialty drug distribution to Medco, which was spun off from Merck in 2003. Accredo's revenues for 2004 where $1.7 billion. Deal value more... | ||
| Distribution | Owens & Minor Inc. (OMI) | Access Diabetic Supply, LLC |
| Adds blood glucose monitor devices and other diabetic lines. $32 million in more... | ||
| Medical Devices | Accuray Inc. | American Science and Engineering, Inc. (ASEI) |
| A sale of certain assets giving Accuray exclusive rights to linear accelerators for medical application. Provides a component of Accuray’s more... | ||
| Medical Devices | Ampac Packaging, LLC (Ampac) | Flexicon, Inc. |
| Grows Ampac’s consumer more... | ||
| Medical Devices | Biolase Technology, Inc. (BLTI) | Diodem, LLC |
| 8 synergetic patents. Deal value about $10 more... | ||
| Medical Devices | Biophan Technologies, Inc. (OTCBB:BIPH) | AMRIS GmbH |
| Enhances Biopan's MRI-related products and adds technical personnel and management within European more... | ||
| Medical Devices | Boston Scientific Corporation (BSX) | Advanced Stent Technologies, Inc. (AST) |
| BSX will own Petalä a stent design developed by AST. Petal complements BSX’s paclitaxel-eluting stent technology. Deal value about $120 more... | ||
| Medical Devices | C.R. Bard, Inc. (BCR) | Genyx Medical Inc. |
| Genyx product line augments Bard’s existing line of continence products. Deal value about $60 more... | ||
| Medical Devices | Cardium Therapeutics, Inc.. (OTC: CDTP) | InnerCool Therapies, Inc. |
| Complements Cardium's biologic approach to the treatment of cardiovascular disease. Potential future applications of InnerCool's technology more... | ||
| Medical Devices | Cochlear Ltd. | Nobel Biocare Holing AG |
| Noble and an investor group are divesting a hearing implant subsidiary Entific Medical Systems, which will provide Cochlear with technology to treat more... | ||
| Medical Devices | Cytyc Corporation (CYTC) | Proxima Therapeutics, Inc. |
| Cytyc gains the right to MammoSiteâ, a single use breast cancer treatment. The product had 2004 revenues of about $12.6 million. Deal value more... | ||
| Medical Devices | DiaSys Corporation (DYX) | Biocheck, Inc. and New Biotech |
| Enables DiaSys to advance its growth plan more... | ||
| Medical Devices | dj Orthopedics, Inc. (DJO) | Superior Medical Equipment, LLC (SME) |
| Superior increases dj's penetration in the New England market, as well as adding new products. Superior Superior’s annual revenues are more... | ||
| Medical Devices | Eastman Kodak Company (EK) | OREX Computed Radiography Ltd. |
| Gives Kodak access to orthopedics, imaging centers and dentistry markets that favor compact CR products. Complements Kodak’s existing products more... | ||
| Medical Devices | Encore Medical Corporation (ENMC) | Osteoimplant Technology, Inc. |
| Adds proprietary spinal fixation systems and other spinal technologies. Deal value about $16 million, including milestone more... | ||
| Medical Devices | Ethox Corporation | STS duo TEK, Inc. |
| Expands Ethox’s laboratory testing more... | ||
| Medical Devices | Eye Dynamics, Inc. | OrthoNetx, Inc. |
| A synergistic merger in which OrthoNetx's president will become president of the combined more... | ||
| Medical Devices | Illumina, Inc. (ILMN) | CyVera Corporation |
| Will provide Illumina with a comprehensive approach to bead-based assays for biomarkers, R&D and in-vitro and molecular diagnostic opportunities. more... | ||
| Medical Devices | Implant Science | Accurel Systems International |
| Accruel's semiconductor failure analysis systems fit into Implant’s semiconductor unit. Deal value about $11.3 more... | ||
| Medical Devices | Integra Life Sciences Holding Corporation (IART) | Newdeal Technologies |
| Newdeal will provide access to orthopedic markets, synergizes with Integra’s wound care product line and adds to its European direct sales more... | ||
| Medical Devices | Invacare Corporation (NYSE:IVC) | Australian Healthcare Company Pty Ltd. |
| Expands Invacare’s existing product offerings and market presence in the Australian more... | ||
| Medical Devices | Jabil Circuit, Inc. (JBL) | Varian Electronics Manufacturing a subsidiary of Varian (VARI) |
| Jabil adds Varian's electronics manufacturing business specializing in high-complexity products in the medical, aerospace, communications and more... | ||
| Medical Devices | Johnson & Johnson (JNJ) | Closure Medical Corporation |
| In this $370mm cash deal, J&J/Ethicon acquires the Dermabond line of topical adhesives and surgical sealants. The line complements Ethicon's more... | ||
| Medical Devices | Miltex Inc. | MeisterHand Gmbh |
| Expands Miltex’s product line to include over 780 instrument patterns for use in the operating room, surgical center and general practice. Line more... | ||
| Medical Devices | Nordic Capital | Atos Medical AB, a subsidiary of Fisher Scientific International Inc. (FSH) |
| Atos had approximately $38 million in revenues for 2004. Deal value about $110 million. Nordic expects Atos to grow more as an autonomous unit, more... | ||
| Medical Devices | OSI Systems, Inc. (OSIS) | Blease Medical Holdings Limited |
| Expand’s OSI’s preoperative presence in Europe and Asia. Deal value about $8.8 million with the potential for additional $11.8 million more... | ||
| Medical Devices | Otto Bock Healthcare | OrthoRehab Inc. |
| Otto Bock acquires several key rehab lines and service facilities, as well as a sales force to channel Otto Bock products. The OrthoRehab network is more... | ||
| Medical Devices | Siemens Medical Solutions USA, Inc. | CTI Molecular Imaging, Inc. |
| Expands molecular imaging competencies of Siemens Medical Solutions. Deal value about $1 more... | ||
| Medical Devices | St. Jude Medical Inc. (STJ) | Endocardial Solutions, Inc. (ESI) |
| ST. Jude adds proprietary EP systems to its atrial fibrillation solutions. Deal value about $272 more... | ||
| Medical Devices | St. Jude Medical Inc. (STJ) | Velocimed, LLC |
| St. Jude will acquire interventional technolcatheterization technologies supplementing its Angio-Seal vascular closure product line. Deal value about more... | ||
| Medical Devices | Stryker Corporation (SYK) | eTrauma .com Corp |
| Expands Stryker’s electronic medical records and PACS capabilities in orthopedics. eTrauma.com had annual sales of $18 million for 2004. Deal more... | ||
| Medical Devices | Thermo Electron Corporation (TMO) | Niton |
| Extends Thermo's product line. Niton had revenues of $36 million for 2004. Deal value about $40.5 more... | ||
| Medical Devices | Viasys Healthcare Inc. (VAS) | Navion Biomedical Corporation |
| Viasys will own the NAVIGATOR systems which are designed to aid in the correct placement of peripherally interested more... | ||
| Medical Devices | Viasys Healthcare Inc. (VAS) | Micro Medical Ltd. |
| Viasys now owns a number of respiratory products geared toward physician’s office practices and primary care. Micro’s posted revenues of more... | ||
| Medical Devices | Zimmer Holdings, Inc. | Universal Plate Technology |
| The locking system allows Zimmer to apply the design to its own Plate and Screw product more... | ||
| Medical Services | BIOBASE | Proteome Inc. |
| BIOBASE broadens its portfolio and presence in the U.S., Canada, and more... | ||
| Medical Services | Fresenius Medical Care AG (Germany) | Renal Care Group, Inc. |
| The $3.5 billion acquisition solidifies Fresenius' as the leader in dialysis services in the US and provides an excellent strategic and more... | ||
| Medical Services | Onex Corporation | Center for Diagnostic Imaging, Inc. |
| Creates a new platform for Onex to grow in the diagnostic and radiology services market. Deal value about $255 million; annual revenues exceed $125 more... | ||
| Medical Services | Steris Corporation (STE) | Cosmed Group, Inc. |
| Cosmed’s five medical device sterilization locations augment Steris’s Isomedix Services sterilization network. Deal value about $73 more... | ||
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. | ||